Literature DB >> 9259992

The role of oxidative stress in the long-term glycation of LDL.

E J Menzel1, G Sobal, A Staudinger.   

Abstract

Advanced glycation is a major pathway for the posttranslational modification of plasma and tissue proteins. The initiating reaction is the nonenzymatic addition of sugars such as glucose to the primary amino groups of proteins, i.e., mainly to lysine residues. These "early" Schiff base and Amadori products then undergo a series of inter- and intramolecular rearrangements to produce the "late" products termed advanced glycation end products (AGEs). Incubation of LDL with glucose or glucose-6-phosphate produces AGE moieties on both the lipid and apolipoprotein B components. In addition, we tried to generate AGE-LDL by reaction with AGE-peptides (< 10 kD) obtained by enzymatic digestion of long-term glycated fibronectin as a model for connective tissue AGE-peptides. AGE-formation can be assessed by monitoring of fluorescence (370/440 nm) which is easily differentiated from the much lower autofluorescence of oxidized low density lipoproteins (oxLDL). Alternatively, AGE formation was detected by an AGE-specific ELISA using antibodies elicited in rabbits against bovine AGE-RNAse. In the present study we investigated the influence of oxidative stress on the long-term glycation of LDL and the modulation of LDL-oxidation by AGE-modification. We observed (a) that the rate of AGE formation is reduced by BHT/EDTA both on LDL and serum albumin (glycation vs. glycoxidation), (b) long-term glycated LDL is more readily oxidized than unglycated LDL, (c) oxLDL is more prone to AGE-modification, (d) AGE-modification of LDL strongly alters its epitope spectrum and (e) that aminoguanidine at higher concentrations (1-10 mM) inhibits copper-catalyzed LDL oxidation in the way of a classical antioxidant.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259992     DOI: 10.1002/biof.5520060204

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  7 in total

Review 1.  Uremic Toxicity of Advanced Glycation End Products in CKD.

Authors:  Andréa E M Stinghen; Ziad A Massy; Helen Vlassara; Gary E Striker; Agnès Boullier
Journal:  J Am Soc Nephrol       Date:  2015-08-26       Impact factor: 10.121

Review 2.  Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients.

Authors:  Sandeep K Mallipattu; John C He; Jaime Uribarri
Journal:  Semin Dial       Date:  2012-04-30       Impact factor: 3.455

3.  Protective action on human LDL against oxidation and glycation by four organosulfur compounds derived from garlic.

Authors:  Chu-Chyn Ou; Shyh-Ming Tsao; Ming-Cheng Lin; Mei-Chin Yin
Journal:  Lipids       Date:  2003-03       Impact factor: 1.880

Review 4.  Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease?

Authors:  Sandeep K Mallipattu; Jaime Uribarri
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-11       Impact factor: 2.894

Review 5.  Effects of Nutrients on Platelet Function: A Modifiable Link between Metabolic Syndrome and Neurodegeneration?

Authors:  Ilse A C Arnoldussen; Renger F Witkamp
Journal:  Biomolecules       Date:  2021-10-04

6.  Inhibition of Advanced Glycation End-Product Formation by Origanum majorana L. In Vitro and in Streptozotocin-Induced Diabetic Rats.

Authors:  Rosa Martha Perez Gutierrez
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-12       Impact factor: 2.629

7.  Evaluation of antidiabetic, antioxidant and antiglycating activities of the Eysenhardtia polystachya.

Authors:  Rosa Martha Perez Gutierrez; Efren Garcia Baez
Journal:  Pharmacogn Mag       Date:  2014-04       Impact factor: 1.085

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.